Drug intelligence / Profile preview

Osteon III collagen

Development stage
Phase 1
Lead developer
Genoss
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Recombinant Proteins and Enzymes, Hydrogel Systems → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
Administration
Surgical Implantation
01

Overview

Osteon III collagen is a synthetic bone graft material composed of biphasic calcium phosphate—specifically, 60% hydroxyapatite (HA) and 40% beta-tricalcium phosphate (β-TCP)—combined with highly purified type I collagen derived from porcine tendon. This composite is designed to be osteoconductive, supporting new bone formation by providing a scaffold for cell attachment and proliferation. The addition of type I collagen enhances the handling properties and biocompatibility of the graft, making it moldable and easy to use in various dental and orthopedic procedures such as sinus lifts, ridge augmentation, extraction socket grafting, cystic cavity filling, periodontal defects, and guided bone regeneration. The product is resorbable over time as natural bone replaces the graft material[1][4][10].

Brand names
Osteon III Collagen
Other names
OCOsteon 3 CollagenOsteon3 CollagenOsteon-3 Collagen
02

Targets

α10β1 (Integrin alpha 10 beta 1)

Beyond the preview

Go deeper on Osteon III collagen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osteon III collagen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call